Eton Pharmaceuticals (ETON) announced that it will be added to the broad-market Russell 3000 and small-cap Russell 2000 Indexes, effective after the U.S. market closes on June 27, as part of the 2025 Russell Indexes reconstitution.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ETON:
- Eton Pharmaceuticals Holds Annual Stockholders Meeting
- Eton Pharmaceuticals price target raised to $35 from $33 at H.C. Wainwright
- Eton Pharmaceuticals: Buy Rating Affirmed on Khindivi’s FDA Approval and Strong Revenue Growth Prospects
- Eton Pharmaceuticals Gains FDA Approval for KHINDIVI
- Eton Pharmaceuticals announces FDA approval for KHINDIVI